TSXV:BTI.H - Post by User
Comment by
BearDownAZon Jun 14, 2017 2:06pm
142 Views
Post# 26362471
RE:RE:RE:biOasis CEO Dr. Mark Day Releases Details of Corporate Plans
RE:RE:RE:biOasis CEO Dr. Mark Day Releases Details of Corporate PlansJD, with all due respect your argument is bogus. RH stated a year ago in email communication to me that "As for our oncology program we are in the process of preparing for a phase zero study, but the timing for that is predicated on material prep and patient availability." Furthermore, the MD&A from Jan 2017 states "Extensive protocols have been designed and approved and both Dr. Scarpa and the Phase Zero team in Australia are ready to begin these studies." The clear expectation is that the material should have been ready by now to start the studies, not wait up to another year for material prep. There is no sugar coating this JD.
JD wrote: "With respect to manufacturing fusion proteins, over the last year I've told everybody who would listen that the first fusion protein would take 9 months to a year to manufacture....If you're defining Phase 0 as a project then the manufacture of the fusion proteins forms one of the first and most time consuming parts of the critical path to completion of the project. Many other elements of the project can be done concurrently with critical path elements."